Pharma Focus Asia
259 FOLLOWERS
Covers articles related to manufacturing, clinical trials, research and development, strategy, Information technology. Pharma Focus Asia, published by Ochre Media, is the leading pharma title in print and digital versions serving the information needs of key executives from the worlds leading pharmaceutical companies.
Pharma Focus Asia
1w ago
Merck a leading science and technology company has signed a definitive agreement to acquire life science company Mirus Bio for US million Based in Madison Wisconsin USA Mirus Bio is a specialist ..read more
Medivir´s Licensee, Tango Therapeutics, Has Discontinued Development of Its TNG348 Clinical Program
Pharma Focus Asia
1w ago
Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that Medivirs licensee Tango Therapeutics ..read more
Pharma Focus Asia
1w ago
Eisai Co Ltd and Nippon Medac Co Ltd a subsidiary of Medac group announced today that they have launched the antirheumatic agent Metoject Subcutaneous Injection mg Pen mL mg Pen mL mg Pen mL ..read more
Pharma Focus Asia
1w ago
Biogen Inc has revealed its acquisition of Human Immunology Biosciences a privatelyheld biotech firm specializing in targeted therapies for severe immunemediated diseases The deal involves an upfront ..read more
Pharma Focus Asia
1w ago
Bicycle Therapeutics plc a pharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide technology today announced that the company has entered into a securities purchase agreement with certain ..read more
Pharma Focus Asia
1w ago
Cartesian Therapeutics Inc a biotechnology company in the clinicalstage pioneering mRNA cell therapy for autoimmune diseases has announced that the US Food and Drug Administration ..read more
Pharma Focus Asia
1w ago
AGC Biologics and BioConnection a specialized contract manufacturing organization with a focus on aseptic filling of vials and syringes have formed a strategic partnership This collaboration combines ..read more
Pharma Focus Asia
1w ago
Laekna Inc a leading biotechnology company has achieved a significant milestone with the approval from the US Food and Drug Administration for the phase III clinical trial protocol of LAE an AKT inhibitor ..read more
Pharma Focus Asia
1w ago
Providence Therapeutic Holdings Inc a company specializing in messenger RNA and lipid nanoparticle platform technology for vaccine and therapeutic development has joined forces with the Ontario ..read more
Pharma Focus Asia
2w ago
Senti Biosciences Inc a biotechnology company developing nextgeneration cell and gene therapies using its ..read more